coreCARE® Specimen Retrieval

About URO-1

URO-1 is an emerging medical device company developing innovative biopsy instruments to improve prostate cancer diagnosis. Its core technology aims to solve the problem of inadequate tissue sampling by providing longer, less-fragmented cores, which can lead to more accurate pathology and genomic testing. Founded in 2018 and headquartered in Greensboro, NC, the company is privately held and positioned in the diagnostics sector with a clear focus on establishing a new standard of care in soft tissue biopsy.

Therapeutic Areas

Other Prostate Biopsy (Diagnostic) Drugs